BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23823022)

  • 1. A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.
    Dowdy CR; Frederick D; Zaidi SK; Colby JL; Lian JB; van Wijnen AJ; Gerstein RM; Stein JL; Stein GS
    Exp Hematol; 2013 Nov; 41(11):980-991.e1. PubMed ID: 23823022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
    Dowdy CR; Xie R; Frederick D; Hussain S; Zaidi SK; Vradii D; Javed A; Li X; Jones SN; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    Hum Mol Genet; 2010 Mar; 19(6):1048-57. PubMed ID: 20035012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
    Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
    PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
    Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
    Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1.
    Majumder A; Syed KM; Joseph S; Scambler PJ; Dutta D
    J Biol Chem; 2015 May; 290(21):13053-63. PubMed ID: 25847244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1B Expression Is Highly Heterogeneous and Distinguishes Megakaryocytic and Erythroid Lineage Fate in Adult Mouse Hematopoiesis.
    Draper JE; Sroczynska P; Tsoulaki O; Leong HS; Fadlullah MZ; Miller C; Kouskoff V; Lacaud G
    PLoS Genet; 2016 Jan; 12(1):e1005814. PubMed ID: 26808730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
    Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
    BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
    Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
    Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis.
    Bee T; Swiers G; Muroi S; Pozner A; Nottingham W; Santos AC; Li PS; Taniuchi I; de Bruijn MF
    Blood; 2010 Apr; 115(15):3042-50. PubMed ID: 20139099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
    Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
    Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
    Challen GA; Goodell MA
    Exp Hematol; 2010 May; 38(5):403-16. PubMed ID: 20206228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro.
    Lacaud G; Gore L; Kennedy M; Kouskoff V; Kingsley P; Hogan C; Carlsson L; Speck N; Palis J; Keller G
    Blood; 2002 Jul; 100(2):458-66. PubMed ID: 12091336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development.
    Nishimura M; Fukushima-Nakase Y; Fujita Y; Nakao M; Toda S; Kitamura N; Abe T; Okuda T
    Blood; 2004 Jan; 103(2):562-70. PubMed ID: 14504086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
    Bluteau D; Gilles L; Hilpert M; Antony-Debré I; James C; Debili N; Camara-Clayette V; Wagner-Ballon O; Cordette-Lagarde V; Robert T; Ripoche H; Gonin P; Swierczek S; Prchal J; Vainchenker W; Favier R; Raslova H
    Blood; 2011 Dec; 118(24):6310-20. PubMed ID: 21725049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell emergence in the conceptus and the role of Runx1.
    Swiers G; de Bruijn M; Speck NA
    Int J Dev Biol; 2010; 54(6-7):1151-63. PubMed ID: 20711992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelialization and altered hematopoiesis by persistent Etv2 expression in mice.
    Hayashi M; Pluchinotta M; Momiyama A; Tanaka Y; Nishikawa S; Kataoka H
    Exp Hematol; 2012 Sep; 40(9):738-750.e11. PubMed ID: 22659386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.
    Ross K; Sedello AK; Todd GP; Paszkowski-Rogacz M; Bird AW; Ding L; Grinenko T; Behrens K; Hubner N; Mann M; Waskow C; Stocking C; Buchholz F
    Blood; 2012 May; 119(18):4152-61. PubMed ID: 22411870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
    Ran D; Shia WJ; Lo MC; Fan JB; Knorr DA; Ferrell PI; Ye Z; Yan M; Cheng L; Kaufman DS; Zhang DE
    Blood; 2013 Apr; 121(15):2882-90. PubMed ID: 23372166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.
    Yoshimi M; Goyama S; Kawazu M; Nakagawa M; Ichikawa M; Imai Y; Kumano K; Asai T; Mulloy JC; Kraft AS; Takahashi T; Shirafuji N; Kurokawa M
    Eur J Immunol; 2012 Apr; 42(4):1044-50. PubMed ID: 22531928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpl receptor defect leads to earlier appearance of hematopoietic cells/hematopoietic stem cells in the Aorta-Gonad-Mesonephros region, with increased apoptosis.
    Fleury M; Petit-Cocault L; Clay D; Souyri M
    Int J Dev Biol; 2010; 54(6-7):1067-74. PubMed ID: 20711984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.